申请人:Takeda Chemical Industries, Ltd.
公开号:US04150139A1
公开(公告)日:1979-04-17
Novel triazolobenzazepine derivatives of the formula ##STR1## (wherein R.sup.1 and R.sup.2 are hydrogen or alkyl, X is ##STR2## wherein R.sup.3 and R.sup.4 are hydrogen, alkyl, aryl or aralkyl, and R.sup.5 is hydrogen or alkyl), Z is --SR.sup.6, --S(O).sub.n R.sup.6 or --OR.sup.7 (wherein R.sup.6 and R.sup.7 are alkyl or aralkyl, and n is 1 or 2), and Ring A is unsubstituted or substituted with at least one of halogen, lower alkyl, lower alkoxy and trifluoromethyl, and their physiologically acceptable salts have excellent pharmacological activities and are useful as medicines such as muscle-relaxants, analgesics and antiinflammatory drugs.
式子为 ##STR1## 的新型三唑并苯并氮杂环衍生物(其中R.sup.1和R.sup.2为氢或烷基,X为 ##STR2## 其中R.sup.3和R.sup.4为氢、烷基、芳基或芳基烷基,R.sup.5为氢或烷基),Z为--SR.sup.6,--S(O).sub.n R.sup.6或--OR.sup.7(其中R.sup.6和R.sup.7为烷基或芳基烷基,n为1或2),环A未取代或取代至少一个卤素、较低烷基、较低烷氧基和三氟甲基,其生理上可接受的盐具有优异的药理活性,可用作肌肉松弛剂、镇痛剂和抗炎药等药物。